AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cue Biopharma, Inc. Director's Dealing 2021

Jan 6, 2021

34525_dirs_2021-01-06_8ba6ea56-1abf-46d5-9efe-036970b8f85d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2021-01-04

Reporting Person: Fletcher Aaron G.L. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-04	Stock Option (right to buy)	$12.36	A	10000	Acquired	2031-01-03	Common Stock (10000)	Direct

Footnotes

F1: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.

F2: This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date.